These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16125814)

  • 1. The potential for gene-targeted radiation therapy of cancers.
    Panyutin IG; Neumann RD
    Trends Biotechnol; 2005 Oct; 23(10):492-6. PubMed ID: 16125814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy strategies to enhance the effectiveness of cancer radiotherapy.
    Freyta SO; Kim JH; Brown SL; Barton K; Lu M; Chung M
    Curr Opin Mol Ther; 2004 Oct; 6(5):513-24. PubMed ID: 15537053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to enhance cancer radiotherapy employing gene transfer methods.
    Buchsbaum DJ; Raben D; Stackhouse MA; Khazaeli MB; Rogers BE; Rosenfeld ME; Liu T; Curiel DT
    Gene Ther; 1996 Dec; 3(12):1042-68. PubMed ID: 8986431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor hypoxia and targeted gene therapy.
    Greco O; Scott S
    Int Rev Cytol; 2007; 257():181-212. PubMed ID: 17280898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of gene therapy for cancers].
    Kudo-Saito C
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1341-6. PubMed ID: 17876128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for selective targeting of Auger electron emitters to tumor cells.
    O'Donoghue JA
    J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining a future role for radiogenic therapy.
    Kaminski JM; Kaminski RJ; Dicker AP; Urbain JL
    Cancer Treat Rev; 2001 Oct; 27(5):289-94. PubMed ID: 11871865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
    Thorne SH; Contag CH
    Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era of cancer therapy: cancer cell targeted therapies are coming of age.
    Voltz E; Gronemeyer H
    Int J Biochem Cell Biol; 2008; 40(1):1-8. PubMed ID: 17951100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.
    McCarthy HO; Worthington J; Barrett E; Cosimo E; Boyd M; Mairs RJ; Ward C; McKeown SR; Hirst DG; Robson T
    Gene Ther; 2007 Feb; 14(3):246-55. PubMed ID: 17006546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic targeted radionuclide therapy: potential new areas.
    Wong JY
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?
    Labialle S; Dayan G; Michaud M; Barakat S; Rigal D; Baggetto LG
    Semin Oncol; 2005 Dec; 32(6):583-90. PubMed ID: 16338424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer.
    Hamakawa H; Nakashiro K; Sumida T; Shintani S; Myers JN; Takes RP; Rinaldo A; Ferlito A
    Head Neck; 2008 Jun; 30(6):800-9. PubMed ID: 18429007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes.
    Wu Q; Gaddis SS; MacLeod MC; Walborg EF; Thames HD; DiGiovanni J; Vasquez KM
    Mol Carcinog; 2007 Jan; 46(1):15-23. PubMed ID: 17013831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.